Ayodeji Adegunsoye Selected Research

Ayodeji Adegunsoye Research Topics

Disease

12	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 01/2016
7	Idiopathic Pulmonary Fibrosis 01/2021 - 01/2015
5	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2021 - 01/2016
4	Pulmonary Hypertension 09/2021 - 01/2015
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2017 - 01/2015
3	Lung Diseases (Lung Disease) 01/2017 - 01/2015
2	COVID-19 04/2022 - 01/2021
2	Disease Progression 11/2021 - 01/2015
2	Neoplasms (Cancer) 10/2020 - 01/2017
2	Idiopathic Interstitial Pneumonias 01/2019 - 07/2017
2	Fibrosis (Cirrhosis) 01/2019 - 12/2016
2	Connective Tissue Diseases (Connective Tissue Disease) 12/2016 - 12/2016
2	Hypoxia (Hypoxemia) 01/2015 - 01/2015
1	Rheumatoid Arthritis 11/2021
1	Lymphadenopathy 11/2021
1	Infections 11/2021
1	Pulmonary Edema 01/2021
1	Ischemia 01/2021
1	Bone Marrow Failure Disorders 10/2020
1	Myositis (Idiopathic Inflammatory Myopathies) 07/2020
1	Vasculitis (Vasculitides) 10/2019
1	Bronchiectasis 12/2017
1	Respiratory Insufficiency (Respiratory Failure) 01/2017
1	Autoimmune Diseases (Autoimmune Disease) 01/2017
1	Obesity 01/2015
1	Hyperaldosteronism (Conn Syndrome) 01/2015
1	Heart Failure 01/2015
1	Gastroesophageal Reflux (GERD) 01/2015
1	Obstructive Sleep Apnea 01/2015
1	Clinical Deterioration 01/2015

Drug/Important Bio-Agent (IBA)

3	AntigensIBA 10/2020 - 01/2016
3	AntibodiesIBA 07/2020 - 01/2019
2	Antinuclear AntibodiesIBA 10/2021 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2019
2	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2020
2	CytokinesIBA 01/2019 - 01/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	Rheumatoid FactorIBA 11/2021
1	Rituximab (Mabthera)FDA Link 11/2021
1	Oxygen (Dioxygen)IBA 09/2021
1	tert-butylserineIBA 10/2020
1	OsteopontinIBA 10/2020
1	ChemokinesIBA 10/2020
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 10/2020
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 10/2020
1	Ligases (Synthetase)IBA 07/2020
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2019
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2019
1	telomerase RNA (bTR)IBA 01/2019
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2019
1	Acetylcysteine (Siran)FDA LinkGeneric 02/2018
1	Azathioprine (Imuran)FDA LinkGeneric 12/2016
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2016
1	Protein Kinase CIBA 01/2015
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015
1	LipopolysaccharidesIBA 01/2015
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2015
1	InterleukinsIBA 01/2015
1	Endothelins (Endothelin)IBA 01/2015
1	Interferon-gamma (Interferon, gamma)IBA 01/2015
1	Inflammation MediatorsIBA 01/2015
1	Chemotactic FactorsIBA 01/2015
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 01/2015
1	Tissue Inhibitor of MetalloproteinasesIBA 01/2015
1	CXC ChemokinesIBA 01/2015
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2015
1	CalciumIBA 01/2015
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2015
1	rho-Associated KinasesIBA 01/2015
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2015
1	Alkaline PhosphataseIBA 01/2015
1	Phosphodiesterase 5 InhibitorsIBA 01/2015

Therapy/Procedure

9	Therapeutics 04/2022 - 01/2015
3	Lung Transplantation 07/2017 - 01/2016
1	Drug Therapy (Chemotherapy) 01/2021
1	Traction 12/2017
1	Transplantation 01/2017